Heart Disease Trial, Recruiting NCT05015660 Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT05015660
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People whose heart is pumping at more than 35% of its normal capacity (a measure called ejection fraction)
  • People who need a heart pacemaker due to a significant electrical conduction problem between the upper and lower chambers of the heart, where the pacemaker is expected to be active more than 90% of the time — this includes complete heart block, certain types of partial heart block, or a significantly delayed electrical signal in the heart
  • People who have had a heart ultrasound (echocardiogram) within the last 3 months, with the digital images available in a standard medical format (DICOM)

Who may not be able to join:

  • People who need a type of device called an implantable cardioverter defibrillator (a device that delivers a shock to correct dangerous heart rhythms)
  • People who have an artificial (mechanical) tricuspid heart valve
  • People who have previously had any attempt at implanting certain types of heart devices, including a defibrillator, a cardiac resynchronisation therapy device, or specific types of pacemakers that target the heart's natural conduction system
  • People who are not able to give informed consent on their own behalf
  • People who have another serious medical illness where life expectancy is expected to be less than 2 years
  • People who are pregnant
  • People whose heart conduction problem is expected to be temporary or likely to recover on its own over time
  • People who have permanent atrial fibrillation (a long-term irregular heart rhythm in the upper chambers of the heart)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 514-934-1934

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Registry
ClinicalTrials.gov
Start date
1 September 2022
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Time to cardiovascular death; Time to first heart failure event; Worsening LV end systolic volume index by 2 years

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov